RPG Life Sciences Receives GST Order: ₹1.08 Crore Demand
RPG Life Sciences received a GST order for the tax period April 2021-March 2022. The total demand includes ₹52.85 lakh tax, ₹44.40 lakh interest, and ₹10.57 lakh penalty, amounting to ₹1.08 crore. The company plans to contest the demand and does not foresee a material financial impact.
The company has stated that it does not foresee any material financial impact on its operations due to this order, and it plans to contest the demand legally.
The company has received a GST order with a financial demand. While they intend to contest it and do not foresee a material impact, the existence of a demand from a tax authority introduces a neutral to slightly negative element.
RPG Life Sciences Limited has received an order from the GST Authority, Maharashtra, concerning the tax period April 2021 to March 2022.
The order, received on December 29, 2025, pertains to a demand of ₹52,85,230 in tax, ₹44,39,593 in interest, and ₹10,57,046 in penalty, totaling ₹1,07,81,869 (approximately ₹1.08 crore).
The company is currently reviewing the order and intends to contest the demand by seeking appropriate legal remedies. RPG Life Sciences Limited does not anticipate any material financial impact on its operations as a result of this order.
What to do with a filing like this
RPG Life Sciences Limited filed this with the NSE as a statutory disclosure, categorised under regulatory impact. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by RPG Life Sciences Limited. Read the original for the full detail.